Subretinal injection in mice to study retinal physiology and disease

Peirong Huang, Siddharth Narendran, Felipe Pereira, Shinichi Fukuda, Yosuke Nagasaka, Ivana Apicella, Praveen Yerramothu, Kenneth M. Marion, Xiaoyu Cai, Srinivas R. Sadda, Bradley D. Gelfand, Jayakrishna Ambati

Published: 2022-04-12 DOI: 10.1038/s41596-022-00689-4

Subretinal injection

Retinal physiology

Standardized protocol

Mice model

Proficiency training

AI 解读

Author Correction: Full-length sequencing of circular DNA viruses and extrachromosomal circular DNA using CIDER-Seq

Generation of heart-forming organoids from human pluripotent stem cells

Design and fabrication of wearable electronic textiles using twisted fiber-based threads

Activation of mechanoluminescent nanotransducers by focused ultrasound enables light delivery to deep-seated tissue in vivo

Chromatin accessibility profiling by ATAC-seq

Deoxyfluorination of phenols for chemoselective18F-labeling of peptides

Author Correction: cfSNV: a software tool for the sensitive detection of somatic mutations from cell-free DNA

Human primordial germ cell-like cells specified from resetting precursors develop in human hindgut organoids

An inexpensive semi-automated sample processing pipeline for cell-free RNA extraction

Application of CHyMErA Cas9-Cas12a combinatorial genome-editing platform for genetic interaction mapping and gene fragment deletion screening

查看全部

Sections

Figures

References

Subretinal injection (SRI) is a widely used technique in retinal research and can be used to deliver nucleic acids, small molecules, macromolecules, viruses, cells or biomaterials such as nanobeads. Here we describe how to undertake SRI of mice. This prot
Introduction
Materials
Procedure
Troubleshooting
Timing
Anticipated results
- References
References
ACKNOWLEDGMENTS

Sharma, S. et al. Pneumatic displacement of submacular hemorrhage with subretinal air and tissue plasminogen activator: initial United States experience. Ophthalmol. Retin. 2, 180–186 (2018).
Herbert, E. N., Groenewald, C. & Wong, D. Treatment of retinal folds using a modified macula relocation technique with perfluoro-hexyloctane tamponade. Br. J. Ophthalmol. 87, 921–922 (2003).
Russell, S. et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390, 849–860 (2017).
Pang, J. J. et al. Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis. Mol. Ther. 13, 565–572 (2006).
Ling, S. et al. Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice. Nat. Biomed. Eng. 5, 144–156 (2021).
Sun, J. et al. Protective effects of human iPS-derived retinal pigmented epithelial cells in comparison with human mesenchymal stromal cells and human neural stem cells on the degenerating retina in rd1 mice. Stem Cells 33, 1543–1553 (2015).
Kaneko, H. et al. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 471, 325–330 (2011).
Tarallo, V. et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149, 847–859 (2012).
Dridi, S. et al. ERK1/2 activation is a therapeutic target in age-related macular degeneration. Proc. Natl Acad. Sci. USA. 109, 13781–13786 (2012).
Kerur, N. et al. TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy. Invest. Ophthalmol. Vis. Sci. 54, 7395–7401 (2013).
Fowler, B. J. et al. Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity. Science 346, 1000–1003 (2014).
Kim, Y. et al. DICER1/Alu RNA dysmetabolism induces Caspase-8-mediated cell death in age-related macular degeneration. Proc. Natl Acad. Sci. USA. 111, 16082–16087 (2014).
Gelfand, B. D. et al. Iron toxicity in the retina requires Alu RNA and the NLRP3 inflammasome. Cell Rep. 11, 1686–1693 (2015).
Kerur, N. et al. cGAS drives noncanonical-inflammasome activation in age-related macular degeneration. Nat. Med. 24, 50–61 (2018).
Narendran, S. et al. Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-beta induced retinal pigmented epithelium degeneration. Signal Transduct. Target Ther. 6, 149 (2021).
Fukuda, S. et al. Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration. Proc. Natl Acad. Sci. USA 118, e2022751118 (2021).
Fukuda, S. et al. Alu complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunity. Sci. Adv. 7, eabj3658 (2011).
Little, C. W. et al. Transplantation of human fetal retinal pigment epithelium rescues photoreceptor cells from degeneration in the Royal College of Surgeons rat retina. Invest. Ophthalmol. Vis. Sci. 37, 204–211 (1996).
Peng, Y., Tang, L. & Zhou, Y. Subretinal injection: a review on the novel route of therapeutic delivery for vitreoretinal diseases. Ophthalmic Res. 58, 217–226 (2017).
Iriyama, A. et al. A2E, a component of lipofuscin, is pro-angiogenic in vivo. J. Cell Physiol. 220, 469–475 (2009).
Lyzogubov, V. V., Tytarenko, R. G., Liu, J., Bora, N. S. & Bora, P. S. Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization. J. Biol. Chem. 286, 16229–16237 (2011).
Baba, T. et al. A rat model for choroidal neovascularization using subretinal lipid hydroperoxide injection. Am. J. Pathol. 176, 3085–3097 (2010).
Narendran, S. et al. A clinical metabolite of azidothymidine inhibits experimental choroidal neovascularization and retinal pigmented epithelium degeneration. Invest. Ophthalmol. Vis. Sci. 61, 4 (2020).
Shen, D., Wen, R., Tuo, J., Bojanowski, C. M. & Chan, C. C. Exacerbation of retinal degeneration and choroidal neovascularization induced by subretinal injection of Matrigel in CCL2/MCP-1-deficient mice. Ophthalmic Res. 38, 71–73 (2006).
Jo, Y. J. et al. Establishment of a new animal model of focal subretinal fibrosis that resembles disciform lesion in advanced age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 52, 6089–6095 (2011).
Georgiadis, A. et al. Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65. Gene Ther. 23, 857–862 (2016).
Xu, H. et al. Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 55, 1519–1530 (2014).
Kim, K. et al. Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration. Genome Res. 27, 419–426 (2017).
Holmgaard, A. B. et al. Targeted knockout of the Vegfa gene in the retina by subretinal injection of RNP complexes containing Cas9 protein and modified sgRNAs. Mol. Ther. 29, 191–207 (2021).
Holmgaard, A., Alsing, S., Askou, A. L. & Corydon, T. J. CRISPR gene therapy of the eye: targeted knockout of Vegfa in mouse retina by lentiviral delivery. Methods Mol. Biol. 1961, 307–328 (2019).
Wu, L. et al. Subretinal gene delivery using helper-dependent adenoviral vectors. Cell Biosci. 1, 15 (2011).
Huang, R. et al. Functional and morphological analysis of the subretinal injection of human retinal progenitor cells under Cyclosporin A treatment. Mol. Vis. 20, 1271–1280 (2014).
McGill, T. J. et al. Subretinal transplantation of human central nervous system stem cells stimulates controlled proliferation of endogenous retinal pigment epithelium. Transl. Vis. Sci. Technol. 8, 43 (2019).
Jin, Z. B. et al. Stemming retinal regeneration with pluripotent stem cells. Prog. Retin. Eye Res. 69, 38–56 (2019).
Maya-Vetencourt, J. F. et al. Subretinally injected semiconducting polymer nanoparticles rescue vision in a rat model of retinal dystrophy. Nat. Nanotechnol. 15, 698–708 (2020).
Fernandez-Bueno, I., Alonso-Alonso, M. L., Garcia-Gutierrez, M. T. & Diebold, Y. Reliability and reproducibility of a rodent model of choroidal neovascularization based on the subretinal injection of polyethylene glycol. Mol. Vis. 25, 194–203 (2019).
Lambert, N. G. et al. Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration. Exp. Eye Res. 145, 248–257 (2016).
Luo, L. et al. Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1. eLife 2, e00324 (2013).
Luo, L. et al. Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration. ACS Nano 7, 3264–3275 (2013).
Zhang, X. et al. AAV2 delivery of Flt23k intraceptors inhibits murine choroidal neovascularization. Mol. Ther. 23, 226–234 (2015).
Cao, J. et al. A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap. Invest. Ophthalmol. Vis. Sci. 51, 6009–6017 (2010).
Qiu, G. et al. A new model of experimental subretinal neovascularization in the rabbit. Exp. Eye Res. 83, 141–152 (2006).
Timmers, A. M., Zhang, H., Squitieri, A. & Gonzalez-Pola, C. Subretinal injections in rodent eyes: effects on electrophysiology and histology of rat retina. Mol. Vis. 7, 131–137 (2001).
Qi, Y. et al. Trans-corneal subretinal injection in mice and its effect on the function and morphology of the retina. PLoS One 10, e0136523 (2015).
Nickerson, J. M. et al. Subretinal delivery and electroporation in pigmented and nonpigmented adult mouse eyes. Methods Mol. Biol. 884, 53–69 (2012).
Parikh, S. et al. An alternative and validated injection method for accessing the subretinal space via a transcleral posterior approach. J. Vis. Exp. https://doi.org/10.3791/54808 (2016).
Muhlfriedel, R., Michalakis, S., Garcia Garrido, M., Biel, M. & Seeliger, M. W. Optimized technique for subretinal injections in mice. Methods Mol. Biol. 935, 343–349 (2013).
Park, S. W., Kim, J. H., Park, W. J. & Kim, J. H. Limbal approach-subretinal injection of viral vectors for gene therapy in mice retinal pigment epithelium. J. Vis. Exp. https://doi.org/10.3791/53030 (2015).
Bennett, J., Anand, V., Acland, G. M. & Maguire, A. M. Cross-species comparison of in vivo reporter gene expression after recombinant adeno-associated virus-mediated retinal transduction. Methods Enzymol. 316, 777–789 (2000).
Bartuma, H. et al. In vivo imaging of subretinal bleb-induced outer retinal degeneration in the rabbit. Invest. Ophthalmol. Vis. Sci. 56, 2423–2430 (2015).
Matsumoto, H., Miller, J. W. & Vavvas, D. G. Retinal detachment model in rodents by subretinal injection of sodium hyaluronate. J. Vis. Exp. https://doi.org/10.3791/50660 (2013).
Huang, P. et al. The learning curve of murine subretinal injection among clinically trained ophthalmic surgeons. Transl. Vis. Sci. Technol. https://doi.org/10.1167/tvst.11.3.13 (2022).
de Melo, J. & Blackshaw, S. In vivo electroporation of developing mouse retina. Methods Mol. Biol. 1715, 101–111 (2018).
Zambricki, E. A. & Dalecy, L. G. Rat sex differences in anesthesia. Comp. Med. 54, 49–53 (2004).
Pritchett-Corning, K. R., Luo, Y., Mulder, G. B. & White, W. J. Principles of rodent surgery for the new surgeon. J. Vis. Exp. https://doi.org/10.3791/2586 (2011).
Lambert, V. et al. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat. Protoc. 8, 2197–2211 (2013).
Wright, C. B. et al. Chronic Dicer1 deficiency promotes atrophic and neovascular outer retinal pathologies in mice. Proc. Natl Acad. Sci. USA. 117, 2579–2587 (2020).
Wang, S. et al. DDX is an essential mediator of sterile NLRC inflammasome activation. DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAs. Sci. Immunol. (in press).

Subretinal injection in mice to study retinal physiology and disease

Extended

Supplementary information

推荐阅读